Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Atherectomy Devices Market, by Type
1.4.2 LAMEA Atherectomy Devices Market, by Geography
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Atherectomy Devices Market by Type
3.1 LAMEA Directional Atherectomy Market by Country
3.2 LAMEA Rotational Atherectomy Market by Country
3.3 LAMEA Orbital Atherectomy Market by Country
3.4 LAMEA Laser Atherectomy Market by Country
Chapter 4. LAMEA Atherectomy Devices Market by Country
4.1 Brazil Atherectomy Devices Market
4.1.1 Brazil Atherectomy Devices Market by Type
4.2 Argentina Atherectomy Devices Market
4.2.1 Argentina Atherectomy Devices Market by Type
4.3 UAE Atherectomy Devices Market
4.3.1 UAE Atherectomy Devices Market by Type
4.4 Saudi Arabia Atherectomy Devices Market
4.4.1 Saudi Arabia Atherectomy Devices Market by Type
4.5 South Africa Atherectomy Devices Market
4.5.1 South Africa Atherectomy Devices Market by Type
4.6 Nigeria Atherectomy Devices Market
4.6.1 Nigeria Atherectomy Devices Market by Type
4.7 Rest of LAMEA Atherectomy Devices Market
4.7.1 Rest of LAMEA Atherectomy Devices Market by Type
Chapter 5. Company Profiles
5.1 Cardiovascular Systems, Inc.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Regional Analysis
5.1.4 Research & Development Expense
5.1.5 Recent strategies and developments:
5.1.5.1 Collaborations, partnerships and agreements:
5.1.5.2 Acquisition and mergers:
5.2 Avinger, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Product launches:
5.2.1.2 Approval:
5.3 Straub Medical AG
5.3.1 Company Overview
5.4 Boston Scientific Corporation
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expense
5.4.5 Recent strategies and developments:
5.4.5.1 Acquisition and mergers:
5.5 Medtronic PLC (Covidien)
5.5.1 Company overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.5.5 Recent strategies and developments:
5.5.5.1 Acquisition and mergers:
5.5.5.2 Approval:
5.6 Koninklijke Philips N.V.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expenses
5.6.5 Recent strategies and developments:
5.6.5.1 Acquisition and mergers:
5.7 Cardinal Health, Inc. (Cordis)
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Segmental and Regional Analysis
5.8 Terumo Corporation (Terumo IS)
5.8.1 Company Overview
5.8.2 Financial Analysis
5.8.3 Segmental Analysis
5.8.4 Recent strategies and developments:
5.8.4.1 Acquisition and mergers:
5.8.4.2 Expansions:
5.9 Abbott Laboratories
5.9.1 Company Overview
5.9.2 Financial Analysis
5.9.3 Segmental and Regional Analysis
5.9.4 Research & Development Expense
5.9.5 Recent strategies and developments:
5.9.5.1 Acquisition and mergers:
5.1 B. Braun Melsungen AG
5.10.1 Company Overview
5.10.2 Financial Analysis
5.10.3 Segmental and Regional Analysis
5.10.4 Research & Development Expense
Unique Offerings 